Business context and reporting period
The supplied filing is OmniLit Acquisition Corp.’s unaudited Form 10-Q for the quarter ended March 31, 2022—not a filing under the name Syntec Optics Holdings, Inc. OmniLit was a blank-check company seeking a business combination. It had not selected a target or begun substantive target discussions as of quarter-end and had no operating business.
Financial performance and position
- Revenue: No operating revenue; the company expected none before completing a business combination.
- Results: Operating costs were $183,884; trust-account interest was $11,967; net loss was $171,917, or $0.01 per share for both Class A and Class B.
- Cash flow: Cash used in operating activities was $250,852 and cash used in financing activities was $66,435. Cash outside the trust fell by $317,287 to $177,312.
- Assets and liquidity: Total assets were $147.1 million, including $146.6 million in trust-account investments and cash. Current liabilities were $72,501. The trust balance was restricted principally for a business combination or redemptions.
- Debt and obligations: The filing reports no long-term debt or lease obligations. A $5.03 million deferred underwriting fee is payable only if a business combination is completed.
- Equity: Stockholders’ deficit was $4.60 million; 14.375 million public shares were classified as temporary equity at a $10.20 redemption value per share.
Changes versus prior period
Compared with December 31, 2021, cash outside the trust declined from $494,599 to $177,312; current assets fell from $666,507 to $389,909; and total assets decreased from $147.43 million to $147.12 million. Accumulated deficit increased by $171,917, reflecting the quarter’s net loss. The filing provides no Q1 2021 operating-period comparison.
Outlook, risks, and other matters
- Management believed available working capital and borrowing capacity would meet needs through the earlier of a business combination or one year from the filing. The sponsor had committed access to an additional $100,000 if needed; none had been advanced by March 31.
- The stated initial combination period was 15 months from the November 2021 IPO, with up to two three-month extensions possible subject to sponsor funding. The filing identifies February 12, 2023 as the scheduled liquidation date. Failure to complete a combination within the permitted period would generally require redemption of public shares and liquidation.
- Management warned that actual search and transaction costs could exceed available working capital; additional financing might be needed to complete a combination or meet redemptions. The sponsor was not obligated to provide working-capital loans or extensions.
- The sponsor’s trust-protection indemnity may not be collectible: the company had not verified the sponsor’s ability to pay and believed its assets consisted only of company securities. Trust assets could also be subject to creditor claims.
- Management said COVID-19 could adversely affect the company’s position or target search, but the impact was not determinable. No material litigation, material risk-factor changes, or subsequent events requiring disclosure were reported. Disclosure controls were deemed effective.
- No revenue or earnings guidance was provided. The filing noted no material market or interest-rate exposure from its short-term Treasury and money-market investments.
Important facts for investors to verify
- Confirm the intended issuer: this document identifies OmniLit Acquisition Corp., not Syntec Optics Holdings, Inc.
- Check the company’s current business-combination status, deadline, and any extensions or sponsor deposits.
- Assess cash available outside the trust, spending needs, and whether sponsor support or other financing has been obtained.
- Review redemption terms, the deferred underwriting fee, and potential claims against trust assets.
- Confirm whether a later filing provides operating results or developments not covered by this Q1 2022 report.